Wearable devices can detect and predict inflammatory bowel disease flare-ups, Mount Sinai study finds Dr. Kamal Kant Kohli17 Jan 2025 9:45 PM ISTWearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease...
USFDA approves Eli Lilly Omvoh for Crohn's disease Ruchika Sharma16 Jan 2025 11:30 AM ISTIndianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz) for...
Approval of Biocon Biologics Yesintek recommended by EMA Committee Ruchika Sharma16 Dec 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the European...
ELi Lilly Omvoh recommended by CHMP for approval in EU for adults with moderately to severely active Crohn's disease Ruchika Sharma14 Dec 2024 10:30 AM ISTIndianapolis: Eli Lilly and Company has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for...
AGA Issues Key Guidance on Diet and Nutrition in IBD Management: Focus on Malnutrition and Tailored Therapies Medha Baranwal10 Dec 2024 8:30 AM ISTUSA: The American Gastroenterological Association (AGA) has released a new Clinical Practice Update (CPU) focusing on the role of diet and nutritional...
USFDA approves Biocon Biologics Yesintek for Crohn's disease, Ulcerative Colitis, Plaque Psoriasis, Psoriatic Arthritis Ruchika Sharma2 Dec 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the U.S. Food ...
First American Gastroenterological Association living guideline for moderate-to-severe ulcerative colitis Dr. Kamal Kant Kohli26 Nov 2024 8:15 PM ISTThe American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe...
Biocon Biologics secures market entry for Bmab 1200 in Europe, UK, Canada, Japan Ruchika Sharma29 Aug 2024 12:30 PM ISTBangalore: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, announced today that the...
Endoscopic treatment approaches for inflammatory bowel diseases: old friends and new weapons Dr. Kamal Kant Kohli26 Aug 2024 1:15 AM ISTInflammatory bowel diseases (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions affecting the...
Novel PET imaging tool identifies early signs of IBD and predicts response to treatment, suggests study Dr. Kamal Kant Kohli13 Aug 2024 8:00 AM ISTA newly developed imaging method, granzyme B PET, can non-invasively detect inflammatory bowel disease (IBD) and provide a real-time picture of active...
Sandoz unveils biosimilar Pyzchiva across Europe to treat chronic inflammatory diseases Ruchika Sharma28 July 2024 10:30 AM ISTBasel: Sandoz has announced the launch of Pyzchiva (ustekinumab) across Europe. Pyzchiva, developed and registered by Samsung Bioepis, a ustekinumab...
JnJ seeks USFDA approval for Tremfya for moderately to severely active Crohn's disease Ruchika Sharma22 Jun 2024 2:21 PM ISTSpring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
